<DOC>
	<DOCNO>NCT00466791</DOCNO>
	<brief_summary>Evaluate behavioral effect MTS child age 6-12 ADHD</brief_summary>
	<brief_title>Classroom Study Assess Efficacy Safety MTS Pediatric Patients Aged 6-12 With ADHD</brief_title>
	<detailed_description>Evaluate behavioral effect measure SKAMP deportment scale MTS compare placebo child age 6-12 ADHD</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Primary diagnosis ADHD Total score great equal 26 ADHDRSIV IQ great equal 80 Blood pressure measurement within 95th percentile age , gender , height screen baseline Current control ( require restrict medication ) uncontrolled , comorbid psychiatric diagnosis ( except ODD ) Known nonresponder psychostimulant treatment BMI age great 90th percentile History seizure last 2 year Conduct Disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>